Levonorgestrel And Ethinyl Estradiol Kit
Product Images NDC 68180-843

10 FDA label images from Lupin Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Levonorgestrel And Ethinyl Estradiol (NDC 68180-843). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (3b52274e E165 49b0 A771 89eb8ff31ec6 01)

Image (3b52274e E165 49b0 A771 89eb8ff31ec6 01)
A horizontal bar chart depicting the number of women with a blood clot out of 10,000 women years (WY) across four conditions: Non-Pregnant Non-COC User (1 to 5), COC-User (3 to 9), Pregnancy (5 to 20), and Postpartum (12 weeks only) with the highest range of 40 to 65. An asterisk notes Pregnancy data is based on duration assumptions from reference studies.*
FDA Label Image

Image (3b52274e E165 49b0 A771 89eb8ff31ec6 02)

Image (3b52274e E165 49b0 A771 89eb8ff31ec6 02)
A forest plot chart displaying effect estimates comparing Ever COC (Combined Oral Contraceptive) use versus Never COC use and Current COC use versus Never-use from various studies between 2002 and 2017. The chart shows odds ratios (OR), relative risks (RR), and hazard ratios (HR) with confidence intervals along a horizontal axis labeled Effect Estimate, ranging from -1.50 to +2.00.*
FDA Label Image

Image-2 (3b52274e E165 49b0 A771 89eb8ff31ec6 03)

Image-2 (3b52274e E165 49b0 A771 89eb8ff31ec6 03)
Chemical structure of Levonorgestrel showing its molecular formula C21H28O2 and molecular weight 312.4. The diagram depicts the arrangement of atoms and bonds in the Levonorgestrel molecule.*
FDA Label Image

Image-3 (3b52274e E165 49b0 A771 89eb8ff31ec6 04)

Image-3 (3b52274e E165 49b0 A771 89eb8ff31ec6 04)
Chemical structure of Ethinyl Estradiol showing its molecular formula (C20H24O2) and molecular weight (296.4). The structure depicts the arrangement of carbon, hydrogen, and oxygen atoms in the steroid framework characteristic of this active ingredient used in the Levonorgestrel and Ethinyl Estradiol kit by Lupin Pharmaceuticals, Inc.*
FDA Label Image

Image (3b52274e E165 49b0 A771 89eb8ff31ec6 535 1)

Image (3b52274e E165 49b0 A771 89eb8ff31ec6 535 1)
The image shows the front of a contraceptive kit box labeled Levonorgestrel and Ethinyl Estradiol. The dosage form is a kit, and the labeler is Lupin Pharmaceuticals, Inc. The package design features a pattern of stylized flowers forming a vertical shape resembling a pill pack.*
FDA Label Image

Image-4 (3b52274e E165 49b0 A771 89eb8ff31ec6 05)

Image-4 (3b52274e E165 49b0 A771 89eb8ff31ec6 05)
A vertical chart illustrating the effectiveness of various birth control methods, ranked from fewer pregnancies to more pregnancies per 100 women in one year. It categorizes methods from most effective (implants, injections, intrauterine devices, sterilization) through moderately effective (birth control pills, skin patch, vaginal ring with hormones), to less effective (condoms, diaphragm), less reliable methods (no sex during fertile days, spermicide, withdrawal), and least effective (no birth control).*
FDA Label Image

Image-5 (3b52274e E165 49b0 A771 89eb8ff31ec6 06)

Image-5 (3b52274e E165 49b0 A771 89eb8ff31ec6 06)
Instructional diagram showing a 13-week pill-taking schedule for Levonorgestrel and Ethinyl Estradiol oral contraceptive kit. Each week is divided into rows labeled Week 2 to Week 13 with daily markers from Sunday to Saturday. Circles represent daily pill doses with arrows indicating the sequence to follow, starting at Week 2 and progressing through the weeks.*
FDA Label Image

Image (3b52274e E165 49b0 A771 89eb8ff31ec6 537 1)

Image (3b52274e E165 49b0 A771 89eb8ff31ec6 537 1)
Packaging label of Levonorgestrel and Ethinyl Estradiol kit by Lupin Pharmaceuticals, Inc., showing a pill blister pack arranged with tablets in a circular flower pattern and along a vertical strip.*
FDA Label Image

Image-8 (3b52274e E165 49b0 A771 89eb8ff31ec6 07)

Image-8 (3b52274e E165 49b0 A771 89eb8ff31ec6 07)
Packaging label for Levonorgestrel and Ethinyl Estradiol Tablets USP 0.15 mg/0.03 mg by Lupin Pharmaceuticals, Inc. The kit includes 3 extended-cycle wallets, each containing 91 tablets. The label shows the NDC 68180-843-13, directions that the tablets include pink film-coated tablets containing the active ingredients, and distribution information for Lupin Pharmaceuticals in Naples, Florida, and manufacturing in India.*
FDA Label Image

Image-7 (3b52274e E165 49b0 A771 89eb8ff31ec6 08)

Image-7 (3b52274e E165 49b0 A771 89eb8ff31ec6 08)
Packaging label for Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.15 mg/0.03 mg, produced by Lupin Pharmaceuticals, Inc. The label indicates a kit containing 3 extended-cycle blisters of 91 tablets each. The label includes dosage details, product warnings, and distributor information, with Lupin logos and distinct color shading in green and yellow.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.